Most young people eager for COVID-19 vaccine, poll shows

As older teens and young adults become eligible for COVID-19 vaccination across the country, and younger teens await their turn, new survey data suggest a strong readiness that has grown since fall. But just as with older generations, a shrinking but still sizable minority of people age 14 to 24 say they’re not willing to get vaccinated, or that their decision will depend on safety.

Read more

New Report: Vaccine Hesitancy and Acceptance Among Parents

A new report shows parents are more vaccine hesitant and resistant than non-parents (in terms of willingness to vaccinate themselves) across all socioeconomic and demographic groups compared. This pattern is largely driven by younger mothers, who are far more vaccine resistant than younger women who are not mothers. Older parents and fathers show little difference from their non-parent peers.

Read more

Endocrine Society joins ASBMR and other bone health organizations to provide guidance on COVID-19 vaccine and osteoporosis

As COVID-19 vaccines continue to be distributed, the world’s leading bone health research, clinical, and patient advocacy organizations ASBMR, Endocrine Society, AACE, ECTS, NOF, and IOF provide recommendations to assist clinicians in managing osteoporosis treatments for their patients who plan to get vaccinated. The full guidance document with supporting evidence is available at https://www.asbmr.org/about/statement-detail/joint-guidance-on-covid-19-vaccine-osteoporosis

Read more

Mount Sinai Joins Challenge Encouraging Public to Get Vaccinated Against COVID-19

The Mount Sinai Health System is joining medical centers across the United States in a grassroots effort to encourage public participation in vaccinations against COVID-19.

Read more

ACR COVID-19 Vaccine Guidance Recommends Vaccination, Addresses Immunosuppressant Drugs & Patient Concerns

The American College of Rheumatology (ACR) has released its COVID-19 Vaccine Clinical Guidance Summary that provides an official recommendation to vaccinate rheumatology patients with musculoskeletal, inflammatory and autoimmune diseases. Important considerations and caveats on how to approach vaccination are included for patients with high disease activity and/or those taking immunosuppressant treatments.

Read more

Ironing out supply chain kinks key to faster COVID vaccine rollout, expert says

Kinks in new production and distribution supply chains are why COVID-19 vaccines approved for use in the United States have been sluggish finding their way into people’s arms, says an expert in logistics and supply chains at The University of Alabama in Huntsville (UAH), a part of the University of Alabama System.

Read more

NAU’s Pathogen and Microbiome Institute to test Allarity Therapeutics drug as potential therapy for new, highly infectious Coronavirus Variant B117

The testing plan for the “British variant” is based on findings of pre-clinical tests showing stenoparib blocks infection and the replication of SARS-CoV-2, as recently published in peer-reviewed journal mBio.

Read more

NCCN Shares New Guidance Principles for Vaccinating People with Cancer Against COVID-19

The National Comprehensive Cancer Network put out new guidance for COVID-19 vaccinations in people with cancer, based on available evidence plus consensus from top hematology and oncology experts with particular expertise in infectious diseases, vaccine development and delivery, and medical ethics.

Read more

LifeBridge Health Begins COVID-19 Vaccinations of Front-line Caregivers

LifeBridge Health has begun to administer the COVID-19 vaccine to front-line healthcare workers. The first doses of the newly approved Pfizer COVID vaccine arrived at LifeBridge Health on December 17 with 24 team members receiving the vaccine that afternoon at Sinai Hospital.

Read more

American College of Allergy, Asthma, and Immunology Releases Guidance on Risk of Allergic Reactions to the Pfizer-BioNTech COVID-19 Vaccine

With the emergency use authorization of the Pfizer-BioNTech COVID-19 vaccine by the FDA on December 11, 2020, and distribution beginning today, the American College of Allergy, Asthma and Immunology COVID-19 Vaccine Task Force recommends the following guidance related to risk of an allergic reaction on vaccination for those who receive the vaccine.

Read more

Over half of adults over 50 say they’ll get vaccinated against COVID-19, but many will want to wait, poll finds

A new poll of adults ages 50 to 80 suggests that achieving the widespread vaccination against COVID-19 needed to protect this high-risk group and end the pandemic will be an uphill climb, and require clear, transparent communication from health providers and others.

Read more

What We Know: Mount Sinai to Host COVID-19 Research Symposium

The COVID-19 Research Symposium, hosted by the Mount Sinai Clinical Intelligence Center (MSCIC), is a one-day comprehensive review of advances in research by the Mount Sinai Health System to better understand and treat the coronavirus known as COVID-19.

Read more

New York State Department of Health Grants Emergency Use Authorization to Mount Sinai for Quantitative COVID-19 Antibody Test

The Clinical Laboratories of The Mount Sinai Hospital has received emergency use authorization from the New York State Department of Health (NYSDOH) for quantitative use of Mount Sinai’s COVID-19 antibody test, making Mount Sinai’s lab the first in the country to run an authorized, fully quantitative antibody test that can deliver a precise numeric measurement of the level of antibodies in a patient’s blood

Read more

Mount Sinai study finds SARS-CoV-2 induces robust antibody responses stable for at least 3 months

Research from the Mount Sinai Health System, just posted to pre-print server MedRxiv (https://www.medrxiv.org/content/10.1101/2020.07.14.20151126v1), shows that the vast majority (more than

Read more

Expert available to speak about legal response to fraudulent COVID-19 cures and treatments

By: Mark Blackwell Thomas | Published: May 14, 2020 | 12:36 pm | SHARE: As the number of COVID-19 cases in the U.S. continues to increase, one Florida State University researcher said the number of people looking to profit from the misfortune by offering false, unproven cures is also on the rise. There is no known cure for COVID-19 but Chad Marzen, associate professor of law in the FSU College of Business, said that hasn’t stopped opportunists from looking to capitalize off people’s fears.

Read more